Fox Run Management, L.L.C. Legend Biotech Corp Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
A detailed history of Fox Run Management, L.L.C. transactions in Legend Biotech Corp stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 12,924 shares of LEGN stock, worth $463,583. This represents 0.08% of its overall portfolio holdings.
Number of Shares
12,924Holding current value
$463,583% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
229Shares Held
78.4MCall Options Held
229KPut Options Held
372K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$401 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$269 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$238 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$205 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$205 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...